IBD Ventures
The IBD Ventures program funds and supports innovative research-based product development to address unmet needs and improve the lives of people with Crohn's disease and ulcerative colitis.
Funder: Crohn's and Colitis Foundation
Due Dates: August 2026 (Letter of Intent) | February 2026 (Letter of Intent, previous)
Funding Amounts: Up to $500,000 per project per year; typical duration is 12 months with potential for renewal if milestones are met.
Summary: Supports the development of innovative products to improve the lives of people with inflammatory bowel diseases (IBD).
Key Information: LOIs accepted year-round but reviewed biannually; full proposals by invitation only.
Description
The Crohn's & Colitis Foundation's IBD Ventures program is a dedicated funding initiative designed to accelerate the development of novel, research-based products that address unmet needs and improve the quality of life for patients with inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis. The program supports both companies and academic investigators focused on product-oriented research and development, offering not only financial resources but also accelerator support and expert advising to help bring impactful solutions to patients.
